Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Calpain Inhibitor I, ALLN: Practical Guide
2026-09-15
Calpain Inhibitor I, ALLN (SKU A2602) is a DMSO-soluble cysteine-protease inhibitor for probing calpain and cathepsin contributions to apoptosis, inflammation, and ischemia-reperfusion workflows. It should be used as a mechanistic research tool with vehicle, viability, and orthogonal protease controls, not as a diagnostic, therapeutic, or calpain-exclusive reagent.
-
EZ Cap™ mCherry mRNA: Evidence and Workflow
2026-09-14
EZ Cap™ mCherry mRNA is a Cap 1-modified red fluorescent protein mRNA designed for reproducible fluorescent protein expression. Its 5mCTP and ψUTP nucleotides, approximately 100-nucleotide poly(A) tail, and defined citrate formulation support mRNA stability and translation enhancement while reducing innate immune stimulation.
-
EdU Imaging Kits (HF594) for Treg Proliferation
2026-09-14
EdU Imaging Kits (HF594) combine 5-ethynyl-2’-deoxyuridine labeling with HyperFluor™ 594 click chemistry for sensitive S-phase measurements in microscopy and flow cytometry. The workflow is particularly useful for separating Treg identity, differentiation state, and actual proliferative activity in immunometabolic and drug-response studies.
-
Carbenoxolone disodium: Practical Lab Guide
2026-09-13
Carbenoxolone disodium (SKU A8389) is an 11β-hydroxysteroid dehydrogenase inhibitor for exploratory studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is suitable for controlled cell and tissue workflows, but should not be treated as a selective target-validation reagent or an in vivo efficacy treatment when off-target effects and electrolyte-related physiology cannot be separated.
-
Lanabecestat: Designing BACE1 Assays
2026-09-12
Lanabecestat (AZD3293) is a potent, brain-penetrant BACE1 inhibitor for Alzheimer’s disease research. This guide presents an assay-design framework that connects amyloid-beta reduction with synaptic-function readouts for more informative preclinical studies.
-
Lapatinib (GW572016) Research Workflows
2026-09-11
Lapatinib connects receptor-defined kinase inhibition with practical assays for proliferation, cell-cycle arrest, invasion, and angiogenesis. This workflow emphasizes how to interpret activity in HER2-positive models alongside phenotype-first experiments in HER2-negative triple-negative breast cancer systems.
-
Capecitabine in Tumor–Stroma-Aware Drug Discovery
2026-09-11
Capecitabine is more than a 5-fluorouracil prodrug: its translational value depends on where enzymatic activation occurs and how tumor–stroma interactions reshape response. By connecting Capecitabine biology with patient-derived gastric cancer assembloids, this article outlines a more rigorous strategy for preclinical oncology research, biomarker development, and tumor-targeted drug delivery.
-
HyperFluor 488 for Variant-Aware IgG Assays
2026-09-10
Learn how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody supports variant-aware human IgG detection without confusing binding signals with neutralization. This guide translates RQ3025 vaccine findings into practical assay design, controls, and readout decisions.
-
Dextran Sulfate Sodium Salt: Design DSS Repair Assays
2026-09-10
Dextran sulfate sodium salt enables a more informative mouse colitis experiment when injury and repair are measured as separate biological phases. This guide integrates DSS model design with the GPR35–KLF5 epithelial-repair mechanism to improve assay interpretation in ulcerative colitis research.
-
Eltanexor (KPT-8602) Research Workflows
2026-09-09
Eltanexor (KPT-8602) enables practical XPO1 inhibition studies spanning leukemia models, lymphoma systems, colorectal organoids, and chemoprevention research. This guide combines mechanism-aligned assay design, compound-handling guidance, translational comparisons, and troubleshooting strategies for more reproducible data.
-
End-Tethered PEO Density and Uremic Toxin Adsorption
2026-09-09
The reference study establishes a surface-science framework for examining how end-tethered methoxy-PEO chain density affects adsorption of a physiologically composed mixture of 25 uremic toxins. Its central finding is that adsorption depends more on toxin-specific chemical structure than on blood concentration alone, providing a useful basis for designing low-fouling biomedical interfaces for kidney disease settings.
-
HyperFluor™ 488 for Vaccine Assay Decisions
2026-09-08
Discover how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody can connect vaccine-design questions with reproducible serological, cellular, and tissue-based readouts. This guide translates findings from a broad-spectrum SARS-CoV-2 vaccine study into practical secondary-antibody decisions and assay controls.
-
Purmorphamine Workflows for Smoothened Signaling
2026-09-08
Purmorphamine is a practical Smoothened agonist for connecting Hedgehog pathway activation with osteogenic, neural, and insect sensory readouts. This workflow-led guide covers dose planning, cross-species interpretation, assay design, and troubleshooting for more reproducible experiments.
-
Tubastatin A in Post-Resuscitation Myocardial Injury
2026-09-07
A porcine cardiac-arrest study found that Tubastatin A reduced post-resuscitation myocardial dysfunction, cardiac injury biomarkers, and molecular signatures associated with GSDME-mediated pyroptosis and MLKL-mediated necroptosis. The work is important because it connects selective HDAC6 inhibition with convergent regulated cell-death pathways in a clinically relevant large-animal model, while still requiring mechanistic and translational validation.
-
PreScission Protease for dKeap1 Condensate Studies
2026-09-07
PreScission Protease enables controlled removal of affinity and fluorescent tags from dKeap1 constructs, helping researchers distinguish intrinsic condensate behavior from tag-driven artifacts. Its site-specific HRV 3C protease activity and low-temperature workflow are well suited to fragile proteins and structure-sensitive phase-separation assays.